Guidance for industry : nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products.

Bibliographic Details
Corporate Author: Center for Biologics Evaluation and Research (U.S.)
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2008]
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS111638
Description
Item Description:Title from PDF title page (viewed on Apr. 21, 2009).
"Draft guidance."
"July 2008."
Electronic resource.
Physical Description:i, 5 pages : digital, PDF file.
Format:Mode of access: Internet at the FDA CBER Web site. Address as of 4/21/09: http://www.fda.gov/cber/gdlns/natparo.pdf ; current access is available via PURL.
Bibliography:Includes bibliographical references (pages 4-5).